Fundraising Fox4G Clinical
Dover, US · Founded 2016 · Delaware LLC · 3 known investors
Find your way into 4G Clinical
Sign up to see every warm intro you have to 4G Clinical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 4G Clinical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
4G Clinical builds technology and delivery services aimed at reducing avoidable delay in clinical trial execution, serving sponsors, CROs, and research sites. The company works within the clinical research and clinical trial supply space to help therapies reach patients faster.
Founders & leadership
4G Clinical was founded in 2016 by Edward Tourtellotte.
Investors · 3
Schooner Capitallisted by Schooner CapitalBoston
How we know: funding news · prnewswire.com · Not right? Tell us
Western Technology Investmentlisted by Western Technology InvestmentPortola Valley
How we know: westerntech.com · Not right? Tell us
Goldman SachsreportedNew York
How we know: funding news · brecorder.com · Not right? Tell us
Funding
SEC filings, press & company announcements$254.3M disclosed across 4 rounds · 2016–2021
- $230MraisedJun 2021 · 2 sourcesSource ↗
▶$14.6MraisedJan 2020 · 8 investors · Other TechnologyRule 506(b)
▶$14.6MraisedJan 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Edward D. HendersonExecutive Officer, Director
- David KelleherExecutive Officer, Director
- Edward TourtellotteExecutive Officer, Director
- Offering amount
- $14.6M
- Amount sold
- $14.6M
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$7.2MraisedFeb 2019 · 9 investors · Other TechnologyRule 506(b)
▶$7.2MraisedFeb 2019 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Ted HendersonDirector
- David KelleherExecutive Officer, Director
- Edward TourtellotteExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7.2M
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$2.5MraisedFeb 2016 · 3 investors · Other TechnologyRule 506(b)
▶$2.5MraisedFeb 2016 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David KelleherExecutive Officer
- Edward TourtellotteExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
SuvodaSuvoda provides software solutions for managing complex clinical trials, including therapeutic areas such as oncology, central nervous system disorders, and rare disease. It serves pharmaceutical and clinical research customers, helping remove barriers to trial participation and expand access.
AdvarraAdvarra provides clinical research services and technology, including institutional review board (IRB) and institutional biosafety committee (IBC) review, data monitoring, endpoint adjudication, and consulting, along with software platforms for clinical trials. It serves life sciences companies, research sites, and institutions in the clinical research industry.
MedidataMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies working in the same space as 4G Clinical.
In the news
Frequently asked questions
- What does 4G Clinical do?
- 4G Clinical builds technology and delivery services aimed at reducing avoidable delay in clinical trial execution, serving sponsors, CROs, and research sites. The company works within the clinical research and clinical trial supply space to help therapies reach patients faster.
- Who founded 4G Clinical?
- 4G Clinical was founded by Edward Tourtellotte in 2016.
- Who are 4G Clinical's investors?
- 4G Clinical's investors include Schooner Capital, Western Technology Investment, Goldman Sachs.
- How much funding has 4G Clinical raised?
- 4G Clinical has disclosed $254.3M raised across 4 rounds.
- Where is 4G Clinical headquartered?
- 4G Clinical is headquartered in Dover, US.